| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/26/2009 | US20090053240 Novel Immunoglobulin Insertions, Deletions and Substitutions |
| 02/26/2009 | US20090053237 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 02/26/2009 | US20090053234 Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents |
| 02/26/2009 | US20090053233 Cytotoxic Antibody Directed Against Type B Lymphoid Hematopoietic Proliferations |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053230 Anti-ox40l antibodies and methods using same |
| 02/26/2009 | US20090053227 Prostate Specific Genes and The Use Thereof in Design of Therapeutics |
| 02/26/2009 | US20090053226 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/26/2009 | US20090053225 Recombinant antibodies against cd55 and cd59 and uses thereof |
| 02/26/2009 | US20090053224 Lox and loxl2 inhibitors and uses thereof |
| 02/26/2009 | US20090053223 Expression-enhanced polypeptides |
| 02/26/2009 | US20090053222 Inhibitors of CD200 such as antibodies or antisense agents for treating cancer, tumor, leukemia |
| 02/26/2009 | US20090053216 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of non-hodgkins lymphoma; immunotherapy |
| 02/26/2009 | US20090053215 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 02/26/2009 | US20090053214 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders |
| 02/26/2009 | US20090053213 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/26/2009 | US20090053212 Humanized anti-human osteopontin antibody |
| 02/26/2009 | US20090053211 Immunoglobulin with enhanced affinity for Fc gamma R's; immunotherapy; tissue targeted therapy; directed protein evolution |
| 02/26/2009 | US20090053210 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 02/26/2009 | US20090053202 Peptide fragment of LYVE-1 and antibody against the same |
| 02/26/2009 | US20090053195 Biomarkers for acute graft rejection |
| 02/26/2009 | US20090053191 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 02/26/2009 | US20090053167 C-, S- and N-glycosylation of peptides |
| 02/26/2009 | US20090053136 Therapeutic immunoglobulin specific for lymphocyte adhesion protein for killing and/or inhibiting growth of cancer cells |
| 02/26/2009 | CA2734549A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 02/26/2009 | CA2697262A1 Compositions of humanized notch fusion proteins and methods of treatment |
| 02/26/2009 | CA2697252A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 02/26/2009 | CA2696761A1 Human c-fms antigen binding proteins |
| 02/26/2009 | CA2696701A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/26/2009 | CA2696684A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | CA2696597A1 Foxm1 peptide and medicinal agent comprising the same |
| 02/26/2009 | CA2696591A1 Cdh3 peptide and medicinal agent comprising the same |
| 02/26/2009 | CA2696252A1 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 02/26/2009 | CA2696027A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | CA2695484A1 Production method |
| 02/25/2009 | EP2028270A2 Modified recombinant vaccina viruses and uses thereof |
| 02/25/2009 | EP2028193A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 02/25/2009 | EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 02/25/2009 | EP2027867A1 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 02/25/2009 | EP2027291A2 Methods and compositions for antibody therapy |
| 02/25/2009 | EP2027158A1 Method for immunizing an avian species |
| 02/25/2009 | EP2027157A2 Modified humanised anti-interleukin-18 antibodies |
| 02/25/2009 | EP2027156A2 Hepatocyte growth factor (hgf) binding proteins |
| 02/25/2009 | EP2027155A2 Human binding molecules having killing activity against staphylococci and uses thereof |
| 02/25/2009 | EP2027154A2 Immunoglobulin constant region domains with enhanced stability |
| 02/25/2009 | EP2027153A2 Dimeric molecular complexes |
| 02/25/2009 | EP2027151A2 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 02/25/2009 | EP2026837A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 02/25/2009 | EP1439857B1 USE OF BISPECIFIC ANTIBODIES BINDING TO THE ACTIVATING RECEPTOR FcEpsilonRI AND TO THE INHIBITING RECEPTOR OX2Ra (CD200Ra) TO REGULATE IMMUNE RESPONSES |
| 02/25/2009 | EP1345495B1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/25/2009 | EP1301795B1 Method of identifying and/or isolating stem cells |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1142996B1 Monoclonal antibody against apolipoprotein a-i |
| 02/25/2009 | EP1075277B1 Methods for detecting and inhibiting angiogenesis |
| 02/25/2009 | EP0896058B1 Novel semaphorin z and gene encoding the same |
| 02/25/2009 | EP0852587B1 Synthetic peptides that inhibit il-6 activity |
| 02/25/2009 | EP0833912B1 Novel tgf-beta like cytokine |
| 02/25/2009 | EP0815141B2 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 02/25/2009 | CN101375160A Potentiation of apoptosis by monoclonal antibodies |
| 02/25/2009 | CN101374957A Method for measuring cholesterol in remnant-like lipoprotein |
| 02/25/2009 | CN101374944A Methods for obtaining immortalized antibody secreting cells |
| 02/25/2009 | CN101374865A Anti-OX40l antibodies and methods using same |
| 02/25/2009 | CN101374864A Il-17 antagonistic antibodies |
| 02/25/2009 | CN101374863A Immunoglobulins directed against NOGO |
| 02/25/2009 | CN101374862A Methods and compositions for targeting polyubiquitin |
| 02/25/2009 | CN101374859A A novel surface exposed haemophilus influenzae protein (protein e; pE) |
| 02/25/2009 | CN101371924A Therapy of autoimmune disease in a patient with an inadequate response to a TNF-ALPHA inhibitor |
| 02/25/2009 | CN100464566C Method and equipment of changed digital color image |
| 02/25/2009 | CN100463967C Testicular carnitine transfer protein and its gene |
| 02/25/2009 | CN100463694C Virus coat protein/receptor chimeras and methods of use |
| 02/24/2009 | US7495091 Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495085 Immunoglobulin for use in diagnosis, prevention and treatment of allergies, autoimmune, inflammatory and cell proliferative disorders |
| 02/24/2009 | US7495084 Polynucleotides, recombinant vectors and host cells for gene expression; antibody fragments |
| 02/24/2009 | US7495083 PRO940 antibodies |
| 02/24/2009 | US7495082 Antibodies to PRO4349 polypeptides |
| 02/24/2009 | US7495081 Framework patched anti-CD20 antibody |
| 02/24/2009 | US7495074 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology |
| 02/24/2009 | US7495071 Antiproliferative peptides and antibodies for their detection |
| 02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/24/2009 | US7494977 Polypeptides homologous to VEGF and BMP1 |
| 02/24/2009 | US7494975 A polyanion selected from a heparin, a dextran, a pentosan, resobene, curdian sulfate, or 2-naphthalene sulfonate polymer and a CD4 polypeptide with a beta-hairpin confirmation; blocking HIV interaction with coreceptors |
| 02/24/2009 | US7494969 a plant-derived protein with anti-cancer properties which binds the human growth hormone-releasing hormone (hGHRH). Said protein, which is obtained from the Pilocarpus Heterophyllus plant, is particularly adapted for preparing a medicament that is intended for the treatment of cancers for which growth |
| 02/24/2009 | US7494824 Interactive system for presenting and eliminating substances |
| 02/24/2009 | US7494800 Which transfer N-acetylgalactosamine to N-acetylglucosamine via beta 1-4 linkage; host cells |
| 02/24/2009 | US7494782 Assay for measuring factor viia-antithrombin complexes |
| 02/24/2009 | US7494779 Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist |
| 02/24/2009 | US7494777 Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 02/24/2009 | US7494656 virus-like particle comprising at least one protein and mutein bound to influenza antigens or epitopes, used for inducing immune responsesv in particular antibody responses and for prevention or treatment of infections, allergies, cancer, drug addiction and poisoning |
| 02/24/2009 | US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome |
| 02/24/2009 | US7494653 Inoculating a patient with an effective amount of PcrV antigen; monoclonal antibodies specific for the PcrV antigen |
| 02/24/2009 | US7494652 polyclonal antibodies comprising tumor necrosis factor, b-cell differentiation factor and interferon antibodies, directed to cytokines, used for treatment of septic shock in animals, including humans |
| 02/24/2009 | US7494651 monoclonal antibodies or antigen-binding fragments, that neutralize mature human transforming growth factors, useful for treating cell proliferative disorders in mammals |
| 02/24/2009 | US7494650 Monoclonal antibodies to hepatocyte growth factor |
| 02/24/2009 | US7494648 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 02/24/2009 | US7494647 Chimeric immunoglobulin for prevention and treatment blood, tumor, cardiovascular and urogenital disorders |
| 02/24/2009 | US7494646 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 02/24/2009 | CA2415364C Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |